Literature DB >> 30535960

School-Age Developmental and Educational Outcomes Following Cardiac Procedures in the First Year of Life: A Population-Based Record Linkage Study.

Claire M Lawley1,2,3, David S Winlaw4,5, Gary F Sholler4,5, Andrew Martin6, Nadia Badawi4,7,8, Karen Walker4,7,8, Natasha Nassar4,9, Samantha J Lain9.   

Abstract

The purpose of the study was to evaluate school-age developmental and educational outcomes for children with and without a cardiac procedure in the first year of life to improve understanding of longer-term neurodevelopmental outcomes in children who have had a cardiac procedure for congenital heart disease, the most common serious congenital anomaly. A population-based cohort study using record linkage of state-wide data was undertaken, evaluating children born in New South Wales, Australia, 2001-2007. Those with and without a cardiac procedure in the first year of life with a linked developmental (Australian version Early Development Instrument testing result, age 4-6 years) and/or educational outcome (Australian National Assessment Program result, age 7-9 years) were included. Perinatal, perioperative and sociodemographic factors were examined using multivariable logistic regression models. Of 468,329 eligible children, 768 had a cardiac procedure in the first year of life and 582 were included. For those with a cardiac procedure and developmental outcome (n = 260), 13.1% were classified as having 'special needs' compared to 4.4% without a cardiac procedure. Of those with an educational outcome, after adjusting for perinatal, perioperative and demographic variables, children with a cardiac procedure (n = 396) were twice as likely to score below National Minimum Standard in school literacy and numeracy tests compared to their peers. Significant predictors included low birthweight, parent not completing school and having > 4 re-hospitalisations in their first six years. The developmental and educational trajectory of children who have had a cardiac procedure in their first year remains altered into primary school years. While perioperative factors did not impact outcomes, ongoing health and sociodemographic factors were important in identifying those children at greatest risk.

Entities:  

Keywords:  Cardiac surgery; Congenital heart disease; Developmental disabilities; Paediatrics; School-age population

Mesh:

Year:  2018        PMID: 30535960     DOI: 10.1007/s00246-018-2029-y

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  5 in total

Review 1.  Recent advances in our understanding of neurodevelopmental outcomes in congenital heart disease.

Authors:  Brian R White; Lindsay S Rogers; Matthew P Kirschen
Journal:  Curr Opin Pediatr       Date:  2019-12       Impact factor: 2.856

Review 2.  Chronic pediatric diseases and risk for reading difficulties: a narrative review with recommendations.

Authors:  Donna Perazzo; Ryan Moore; Nadine A Kasparian; Megan Rodts; Tzipi Horowitz-Kraus; Lori Crosby; Brian Turpin; Andrew F Beck; John Hutton
Journal:  Pediatr Res       Date:  2022-02-04       Impact factor: 3.953

Review 3.  'Big issues' in neurodevelopment for children and adults with congenital heart disease.

Authors:  Charlotte E Verrall; Gillian M Blue; Alison Loughran-Fowlds; Nadine Kasparian; Jozef Gecz; Karen Walker; Sally L Dunwoodie; Rachael Cordina; Gary Sholler; Nadia Badawi; David Winlaw
Journal:  Open Heart       Date:  2019-07-03

Review 4.  Neuroplacentology in congenital heart disease: placental connections to neurodevelopmental outcomes.

Authors:  Rachel L Leon; Imran N Mir; Christina L Herrera; Kavita Sharma; Catherine Y Spong; Diane M Twickler; Lina F Chalak
Journal:  Pediatr Res       Date:  2021-04-16       Impact factor: 3.953

Review 5.  Academic achievement and needs of school-aged children born with selected congenital anomalies: A systematic review and meta-analysis.

Authors:  Svetlana V Glinianaia; Ashleigh McLean; Malcolm Moffat; Rebekka Shenfine; Annarita Armaroli; Judith Rankin
Journal:  Birth Defects Res       Date:  2021-10-21       Impact factor: 2.661

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.